Abstract
The conventional vaccines offer effective approaches to control several infectious diseases till date but are not always safe. In search for relatively safer vaccines, the developed new generation vaccines possess weak immunogenicity. Adjuvants are used to potentiate the immune responses induced by vaccine antigens and to achieve a desirable type of response. Heat shock proteins (HSP) are explored as adjuvants as well as therapeutic targets against tumors. HSP are ubiquitous group of proteins conserved in nature and induced to over express during various stressful conditions including heat. HSP are the single most abundant group of proteins inside the cell and during non-apoptotic cell death, they act as danger associated molecular patterns (DAMPs) and recognized by pattern recognition receptors (PRRs) present on the surface or inside the host cells resulting in stimulation of cells involved in immunity. The molecular mechanisms involved in the adjuvant activity of HSP are not fully understood. In this chapter, we will focus on some of the established functions of HSP and study its role as an adjuvant in veterinary vaccines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- APCs:
-
Antigen presenting cells
- CCR5:
-
Chemokine receptor 5
- CTL:
-
Cytotoxic T lymphocyte
- DAMPs:
-
Danger associated molecular patterns
- DCs:
-
Dendritic cells
- GM-CSF:
-
Granulocyte-macrophage colony-stimulating factor;
- gp96:
-
Glucose-regulated protein
- HSP:
-
Heat shock proteins
- IFN-γ:
-
Interferon gamma
- LOX-1:
-
Lectin-like oxidized low-density lipoprotein (LDL) receptor-1
- LRP1:
-
Lipoprotein receptor 1
- MAP:
-
Mycobacterium avium paratuberculosis
- MCP-1:
-
Monocyte chemo attractant protein-1
- MHC:
-
Major histocompatibility complex
- MIP-1:
-
Macrophage inflammatory protein-1
- NOS:
-
Nitric oxide synthetase
- PAMPs:
-
Pathogen associated molecular patterns
- PRRs:
-
Pattern recognition receptors
- RANTES:
-
Regulated upon activation normal T cell expressed and secreted
- SREC-1:
-
Scavenger receptor expressed by endothelial cells-1
- TAP:
-
Transporter associated with antigen processing proteins
- TLRs:
-
Toll-like receptors
- TNF-α:
-
Tumor necrosis factor-alpha
References
Aosai, F., Chen, M., Kang, H. K., et al. (2002). Toxoplasma gondii-derived heat shock proteinHSP70 functions as a B cell mitogen. Cell Stress & Chaperones, 7, 357–364.
Aujla, S. J., Chan, Y. R., Zheng, M., et al. (2008). IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia. Nature Medicine, 14, 275–281.
Basu, S., Binder, R. J., Suto, R., Anderson, K. M., & Srivastava, P. K. (2000). Necrotic not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. International Immunology, 12, 1539–1546.
Basu, S., Binder, R. J., Ramalingam, T., & Srivastava, P. K. (2001). CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity, 14, 303–313.
Berwin, B., Hart, J. P., Rice, S., Gass, C., Pizzo, S. V., Post, S. R., & Nicchitta, C. V. (2003). Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. The EMBO Journal, J22, 6127–6136.
Binder, R. J. (2014). Functions of heat shock proteins in pathways of the innate and adaptive immune system. Journal of Immunology, 193, 5765–5771.
Binder, R. J., & Srivastava, P. K. (2004). Essential role of CD91 in re-presentation of gp96-chaperoned peptides. Proceedings of the National Academy of Sciences, 101, 6128–6133.
Blachere, N. E., Li, Z., Chandawarkar, R. Y., et al. (1997). Heat shock protein–peptide complexes,reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. The Journal of Experimental Medicine, 186, 1315–1322.
Bogers, W. M. J. M., Bergmeier, L. A., Oostermeijer, H., et al. (2004a). CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection. Vaccine, 22, 2974–2984.
Bogers, W. M., Ma, J., Oostermeijer, H., et al. (2004b). A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection. AIDS, 18, 25–36.
Bonato, V. L. D., Goncalves, E. D. C., Soares, E. G., Sartori, A., Coelho-Castelo, A. A., & Silva, C. L. (2004). Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: Activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury. Immunology, 113, 130–138.
Bonorino, C., Nardi, N. B., Zhang, X., & Wysocki, L. J. (1998). Characteristics of the strong antibody response to mycobacterial Hsp70: A primary, T cell-dependent IgG response with no evidence of natural priming or gamma delta T cell involvement. Journal of Immunology, 161, 5210–5216.
Brenner, B. G., & Wainberg, Z. (2001). Heat shock proteins: Novel therapeutic tools for HIV-infection? Expert Opinion on Biological Therapy, 1, 67–77.
Calderwood, S. K., Gong, J., & Murshid, A. (2016). Extracellular HSP: The complicated roles of extracellular HSP in immunity. Frontiers in Immunology, 7, 159.
Chen, Y. L., Wang, S. N., Yang, W. J., Lin, H. H., & Shiuan, D. (2003). Expression and immunogenicity of mycoplasma hyopneumoniae heat shock protein antigen P42 by DNA vaccination. Infection and Immunity, 71, 1155–1160.
Chen, D. X., Su, Y. R., Shao, G. Z., & Qian, Z. C. (2004). Purification of heat shock protein 70-associated tumor peptides and their antitumor immunity to hepatoma in mice. World Journal of Gastroenterology, 10, 361–365.
Cheng, W. F., Hung, C. F., Chai, C. Y., et al. (2001). Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene. Journal of Immunology, 166, 6218–6226.
Colaco, C. A. L. S., Bailey, C. R., Keeble, J., & Walker, K. B. (2004). BCG (Bacille Calmette–Guérin) HspCs (heat-shock protein–peptide complexes) induce T-helper 1 responses and protect against live challenge in a murine aerosol challenge model of pulmonary tuberculosis. Biochemical Society Transactions, 32, 626–628.
Craig, E. A. (1985). The heat shock response. CRC Critical Reviews in Biochemistry, 18, 239–280.
Dakshinamoorthy, G., Samykutty, A. K., Munirathinam, G., Shinde, G. B., Nutman, T., Reddy, M. V., & Kalyanasundaram, R. (2012). Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic Filariasis. PLoS One, 7, e34077.
Dhiman, R., Indramohan, M., Barnes, P. F., Nayak, R. C., Paidipally, P., Rao, L. V., & Vankayalapati, R. (2009). IL-22 Produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. Journal of Immunology, 183, 6639–6623.
Doody, A. D. H., Kovalchin, J. T., Mihalyo, M. A., Hagymasi, A. T., Drake, C. G., & Adler, A. J. (2004). Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function. Journal of Immunology, 172, 6087–6092.
Duan, M. M., Xu, R. M., Yuan, C. X., et al. (2015). SjHSP70, a recombinant Schistosoma Japonicum heat shock protein 70, is immunostimulatory and induces protective immunity against cercarial challenge in mice. Parasitology Research, 114, 3415–3429.
Ebrahimi, S. M., & Tebianian, M. (2010). Heterologous expression, purification and characterization of the influenza a virus M2e gene fused to mycobacterium tuberculosis HSP70(359-610) in prokaryotic system as a fusion protein. Molecular Biology Reports, 37, 2877–2883.
Ebrahimi, S. M., Dabaghian, M., Tebianian, M., & Zabeh, M. H. (2012). In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza a isolates circulating in Iran. Virology, 430, 63–72.
de Filippo, A., Binder, R. J., Camisaschi, C., et al. (2008). Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses. Journal of Immunology, 181, 6525–6535.
Floto, R. A., MacAry, P. A., Boname, J. M., et al. (2006). Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5. Science, 314, 454–468.
Gajadhar, A. A., Pozio, E., Ray Gamble, H., et al. (2009). Trichinella diagnostics and control: Mandatory and best practices for ensuring food safety. Veterinary Parasitology, 159, 197–205.
Galli, V., Simionatto, S., Marchioro, S. B., Fisch, A., Gomes, C. K., Conceição, F. R., & Dellagostin, O. A. (2012). Immunisation of mice with mycoplasma hyopneumoniae antigens P37, P42, P46 and P95 delivered as recombinant subunit or DNA vaccines. Vaccine, 31, 135–140.
Guy, B. (2007). The perfect mix: Recent progress in adjuvant research. Nature Reviews Microbiology, 5, 505–517.
Hirayama, E., Atagi, H., Hiraki, A., & Kim, J. (2004). Heat shock protein 70 is related to thermal inhibition of nuclear export of the influenza virus ribonucleoprotein complex. Journal of Virology, 78, 1263–1270.
Jorge, S., de Oliveira, N. R., Marchioro, S. B., et al. (2014). The mycoplasma hyopneumoniae recombinant heat shock protein P42 induces an immune response in pigs under field conditions. Comparative Immunology, Microbiology and Infectious Diseases, 37, 229–236.
Ju, Y., Fan, H., Liu, J., et al. (2014). Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine. Vaccine, 32, 2703–2711.
Kang, H. K., Lee, H. Y., Lee, Y. N., Jo, E. J., Kim, J. I., Aosai, F., Yano, A., Kwak, J. Y., & Bae, Y. S. (2004). Toxoplasma gondii-derived heat shock protein 70 stimulates the maturation of human monocyte-derived dendritic cells. Biochemical and Biophysical Research Communications, 322, 899–904.
Kaur, T., Sobti, R. C., & Kaur, S. (2011). Cocktail of gp63 and Hsp70 induces protection against Leishmania donovani in BALB/c mice. Parasite Immunology, 33, 95–103.
Koets, A. P., Rutten, V. P. M. G., de Boer, M., Bakker, D., Valentin-Weigand, P., & van Eden, W. (2001). Differential changes in heat shock protein- lipoarabinomannan-, and purified protein derivative-specific immunoglobulin G1 and G2 isotype responses during bovine Mycobacterium Avium subsp. paratuberculosis infection. Infection and Immunity, 69, 1492–1498.
Koets, A., Hoek, A., Langelaar, M., Overdijk, M., Santema, W., Franken, P., Eden, W. V., & Rutten, V. (2006). Mycobacterial 70kD heat-shock protein is an effective subunit vaccine against bovine paratuberculosis. Vaccine, 24, 2550–2559.
Lee, K. P., Raez, L. E., & Podack, E. R. (2006). Heat shock protein–based cancer vaccines. Hematology/Oncology Clinics of North America, 20, 637–659.
Li, Z., & Srivastava, P. (2004). Heat-shock proteins. In Current protocols in immunology (p. appendix 1T). Hoboken: John Wiley.
Li, X., Yang, X., Li, L., Liu, H., & Liu, J. (2006). A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine. Vaccine, 24, 3321–3331.
Li, J., Li, K. N., Gao, J., Cui, J. H., Liu, Y. F., & Yang, S. J. (2008). Heat shock protein 70 fused to or complexed with hantavirus nucleocapsid protein significantly enhances specific humoral and cellular immune responses in C57BL/6 mice. Vaccine, 26, 3175–3187.
Li, G., Zhang, J., Tong, X., Li, G., Zhang, J., Tong, X., Liu, W., & Ye, X. (2011). Heat shock protein 70 inhibits the activity of influenza a virus ribonucleoprotein and blocks the replication of virus in vitro and in vivo. PLoS One, 6, e16546.
Long, K. H., Gomez, F. J., Morris, R. E., & Newman, S. L. (2003). Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. Journal of Immunology, 170, 487–494.
Maity, H. K., Dey, S., Mohan, C. M., Khulape, S. A., Pathak, D. C., & Vakharia, V. N. (2015). Protective efficacy of a DNA vaccine construct encoding the VP2 gene of infectious bursal disease and a truncated HSP70 of mycobacterium tuberculosis in chickens. Vaccine, 33, 1033–1039.
Manjili, M. H., Park, J., Facciponte, J. G., & Subjeck, J. R. (2005). HSP110 induces “danger signals” upon interaction with antigen presenting cells and mouse mammary carcinoma. Immunobiology, 210, 295–303.
Matsutake, T., Sawamura, T., & Srivastava, P. K. (2010). High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules. Cancer Immunity, 10, 7.
Mun, H. S., Aosai, F., Norose, K., Chen, M., Piao, L. X., Takeuchi, O., Akira, S., Ishikura, H., & Yano, A. (2003). TLR2 as an essential molecule for protective immunity against toxoplasma gondii infection. International Immunology, 15, 1081–1087.
Murshid, A., Borges, T. J., & Calderwood, S. K. (2015). Emerging roles for scavenger receptor SREC-I in immunity. Cytokine, 75, 256–260.
Murshid, A., Borges, T. J., Lang, B. J., & Calderwood, S. K. (2016). The scavenger receptor SREC-I cooperates with toll-like receptors to trigger inflammatory innate immune responses. Frontiers in Immunology, 7, 226.
Negash, T., Liman, M., & Rautenschlein, S. (2013). Mucosal application of cationic poly(d, l-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal disease. Vaccine, 31, 3656–3662.
Okuni, J. B., Kateete, D. P., Okee, M., Nanteza, A., Joloba, M., & Ojok, L. (2017). Application of antibodies to recombinant heat shock protein 70 in immunohistochemical diagnosis of mycobacterium avium subspecies paratuberculosis in tissues of naturally infected cattle. Irish Veterinary Journal, 70, 10.
Oura, J., Tamura, Y., Kamiguchi, K., Kutomi, G., Sahara, H., Torigoe, T., Himi, T., & Sato, N. (2011). Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells. International Immunology, 23, 223–237.
Park, J. E., Facciponte, J., Chen, X., MacDonald, I., Repasky, E. A., Manjili, M. H., Wang, X. Y., & Subjeck, J. R. (2006). Chaperoning function of stress protein grp170, a member of the hsp70 superfamily, is responsible for its immunoadjuvant activity. Cancer Research, 66, 1161–1168.
Parmiani, G., Testori, A., Maio, M., Castelli, C., Rivoltini, L., Pilla, L., Belli, F., Mazzaferro, V., Coppa, J., Patuzzo, R., Sertoli, M. R., Hoos, A., Srivastava, P. K., & Santinami, M. (2004). Heat shock proteins and their use as anticancer vaccines. Clinical Cancer Research, 10, 8142–8146.
Qazi, K. R., Qazi, M. R., Julián, E., Singh, M., Abedi-Valugerdi, M., & Fernández, C. (2005). Exposure to mycobacteria primes the immune system for evolutionarily diverse heat shock proteins. Infection and Immunity, 73, 7687–7696.
Ramon, G. (1924). Sur la toxine et sur l’anatoxine diphtheriques. Annales de l'Institut Pasteur, 38, 1–10.
Rico, A. I., Gironès, N., Fresno, M., Alonso, C., & Requena, J. M. (2002). The heat shock proteins, Hsp70 and Hsp83, of Leishmania infantum are mitogens for mouse B cells. Cell Stress & Chaperones, 7, 339–346.
Ritossa, F. (1962). A new puffing pattern induced by temperature shock and DNP in drosophila. Experientia, 18, 571–573.
Sanchez, G. I., Sedegah, M., Rogers, W. O., Jones, T. R., Sacci, J., Witney, A., Carucci, D. J., Kumar, N., & Hoffman, S. L. (2001). Immunogenicity and protective efficacy of a plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice. Infection and Immunity, 69, 3897–3905.
Scheckelhoff, M., & Deepe, G. S. (2002). The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V beta 8.1/8.2+ T cells. Journal of Immunology, 169, 5818–5826.
Schulz, S. M., Köhler, G., Schütze, N., et al. (2008). Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. Journal of Immunology, 181, 7891–7901.
Simionatto, S., Marchioro, S. B., Galli, V., et al. (2012). Immunological characterization of mycoplasma hyopneumoniae recombinant proteins. Comp. Immunol. Microbiol. Infectious Diseases, 35, 209–216.
Srivastava, P. (2002). Roles of heat-shock proteins in innate and adaptive immunity. Nature Reviews Immunology, 2, 185–194.
Srivastava, P. K., DeLeo, A. B., & Old, L. J. (1986). Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proceedings of the National Academy of Sciences of the United States of America, 83, 3407–3411.
Suzue, K., Zhou, X., Eisen, H. N., & Young, R. A. (1997). Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proceedings of the National Academy of Sciences of the United States of America, 94(13), 146–151.
Udono, H., & Srivastava, P. K. (1993). Heat shock protein 70-associated peptides elicit specific cancer immunity. Journal of Experimental Medicine, 178, 1391–1396.
Udono, H., & Srivastava, P. K. (1994). Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. Journal of Immunology, 152, 5398–5403.
Udono, H., Yamano, T., Kawabata, Y., Ueda, M., & Yui, K. (2001). Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. International Immunology, 13, 1233–1242.
Uto, T., Tsujimura, K., Uchijima, M., et al. (2011). A novel vaccine strategy to induce mycobacterial antigen-specific Th1 responses by utilizing the C-terminal domain of heat shock protein 70. FEMS Immunology and Medical Microbiology, 61, 189–196.
Wang, S., Zhu, X., Yang, Y., et al. (2009). Molecular cloning and characterization of heat shock protein 70 from Trichinella spiralis. Acta Tropica, 110, 46–51.
Warger, T., Hilf, N., Rechtsteiner, G., et al. (2006). Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. The Journal of Biological Chemistry, 281, 22545–22553.
Williams, J. H. H., & Ireland, H. E. (2007). Sensing danger--Hsp72 and HMGB1 as candidate signals. Journal of Leukocyte Biology, 83, 489–492.
Wolk, K., & Sabat, R. (2006). Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine & Growth Factor Reviews, 17, 367–380.
Wu, S., Hong, F., Gewirth, D., Guo, B., Liu, B., & Li, Z. (2012). The molecular chaperone gp96/GRP94 interacts with toll-like receptors and integrins via its C-terminal hydrophobic domain. The Journal of Biological Chemistry, 287, 6735–6742.
Wu, J., Liu, T., Rios, Z., Mei, Q., Lin, X., & Cao, S. (2017). Heat shock proteins and cancer. Trends in Pharmacological Sciences 38, 226–256.
Yang, Y., Liu, B., Dai, J., et al. (2007). Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity, 26, 215–226.
Yang, Y., Zhang, Z., Yang, J., Chen, X., Cui, S., & Zhu, X. (2010). Oral vaccination with Ts87 DNA vaccine delivered by attenuated salmonella typhimurium elicits a protective immune response against Trichinella spiralis larval challenge. Vaccine, 28, 2735–2742.
Yang, P., Wang, W., Gu, H., et al. (2014). Protection against influenza H7N9 virus challenge with a recombinant NP–M1–HSP60 protein vaccine construct in BALB/c mice. Antiviral Research, 111, 1–7.
Yuan, J., Kashiwagi, S., Reeves, P., et al. (2014). A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma. Journal of Hematology & Oncology, 7, 15.
Zhang, L., Ma, L., Liu, R., et al. (2012). Eimeria tenella heat shock protein 70 enhances protection of recombinant microneme protein MIC2 subunit antigen vaccination against E.Tenella challenge. Veterinary Parasitology, 188, 239–246.
Zheng, Y., Valdez, P. A., Danilenko, D. M., et al. (2008). Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Medicine, 14, 282–289.
Acknowledgements
We thank the Director, Indian Veterinary Research Institute, for supporting and extending the facilities. A part of this work was supported by a research grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India (BT/PR12518/ADV/57/01/2009). We also acknowledge Dr. Sinéad Lyons, Postdoctoral Research Associate, School of Biological Sciences, University of Reading for proof reading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Dey, S. et al. (2017). Heat Shock Protein as an Adjuvant in Veterinary Vaccines. In: Asea, A., Kaur, P. (eds) Heat Shock Proteins in Veterinary Medicine and Sciences. Heat Shock Proteins, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-319-73377-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-73377-7_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73376-0
Online ISBN: 978-3-319-73377-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)